1 / 10

Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers

Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers. John M. Eisenberg Clinical Decisions and Communications Science Center Agency for Healthcare Research and Quality Effective Health Care Program. Themes. Drugs Consumers Harms and Benefits Communication. Goals.

topanga
Download Presentation

Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers John M. Eisenberg Clinical Decisions and Communications Science Center Agency for Healthcare Research and Quality Effective Health Care Program

  2. Themes • Drugs • Consumers • Harms and Benefits • Communication

  3. Goals • Identify best practices • Identify gaps in the research • Help guide the Eisenberg Center’s work developing translational products for consumers, clinicians and policy-makers, based on Comparative Effectiveness Reviews from AHRQ’s Effective Health Care Program

  4. Task to Presenters • Explore assigned topic: • Evidence • Best Practice • Gaps in Knowledge • Outline and presentation today • White paper products

  5. Schedule • Morning • Introduction • Three presentations • Discussion of presentations • Lunch • Afternoon • Two presentations • Discussion of presentations • Recommendations for practice & research

  6. Morning Presentations • Innovative Methods of Communicating Harms and Benefits of Drug Treatment • Isaac Lipkus, PhD • Communicating Harm and Benefit to Vulnerable Populations • Gary Kreps, PhD • Communicating Uncertainty • Mark Schleinitz, MD, MS and Colleagues

  7. Afternoon Presentations • Marketing Evidence: What does Social Marketing have to offer? • Douglas Evans, PhD • Communication of Harms and Benefits by Journalists and the Broader Media: What can we Learn? • Michael Wilkes, MD, PhD

  8. What’s in your folder? • List of presenters and biosketches • List of participants • Presentation slides, abstracts and outlines • Draft consumer and clinician versions of 2 Eisenberg Center information products: • Analgesics for osteoarthritis • Second generation antidepressants • Drafts for your information, not for circulation please • Travel reimbursement information

  9. What’s Next? • Authors will incorporate your comments and feedback • Review and comment on draft white papers—December 2006 • External peer review and publication

  10. We’re here to help! • Jennifer Brayko • Susan Severance • Jim Wallace • The rest of the Eisenberg Center Staff • If you need something, just ask and we’ll try to help you

More Related